December 1 - 4, 2014
Disney's Contemporary Resort
Orlando, Fla., USA
Abstract submission deadline: Monday, September 15
Advance registration deadline: Friday, October 17
Professional Educational Grants:
AstraZeneca, Genentech, Gilead, Novartis
This AACR Special Conference is designed to provide highly stimulating discussions to further the scientific and translational goals of the field and allow for more effective exchange of ideas among basic cancer immunologists, non-immunologists, and clinical scientists. The central theme of this year’s conference is to discuss the advances made in basic and translational tumor immunology across multiple disciplines. Important topics to be covered in this meeting are: interaction of radiobiology, antibody effector mechanisms in immune therapy, tumor microenvironment, microbiome, overcoming obstacles to generating adaptive immunity, adoptive-T-cell therapy, metabolism, and novel understanding in the biology of vaccination.
Each plenary session consists of 20- to 25-minute presentations from the leading experts in the field. Highest scoring abstracts will be selected for podium presentations to talk about their innovative research data during the sessions. There will be ample networking opportunities during the breakfast, lunch, and poster sessions where attendees will be able to present and discuss their latest research in an informal setting. This highly comprehensive conference will provide a unique forum allowing for effective exchange of ideas between basic and translational scientists to bridge the gap between discovery and therapy.
Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available
Have a special interest in cancer immunology? If so, consider joining the AACR’s
Cancer Immunology Working Group (CIMM).